Abstract
Adjuvant therapy with antiandrogens vs. gonadotropin releasing hormone agonists combined with radiotherapy and risk of prostate cancer death in men with high-risk prostate cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have